XML 29 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivative Instruments And Hedging Activities (Narrative) (Details) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended 9 Months Ended 1 Months Ended
Feb. 24, 2013
Feb. 26, 2012
Feb. 24, 2013
Feb. 26, 2012
Feb. 24, 2013
Employee-Directed Investments In Darden Stock Within The Non-Qualified Deferred Compensation Plan
Feb. 24, 2013
Commodities futures, swaps & options
Feb. 24, 2013
Minimum
Employee-Directed Investments In Darden Stock Within The Non-Qualified Deferred Compensation Plan
Feb. 24, 2013
Maximum
Employee-Directed Investments In Darden Stock Within The Non-Qualified Deferred Compensation Plan
Feb. 24, 2013
Darden Stock Units
Minimum
Feb. 24, 2013
Darden Stock Units
Maximum
Feb. 24, 2013
5.625% Senior Notes Due October 2012
Senior Notes
Feb. 24, 2013
5.625% Senior Notes Due October 2012
Interest rate swaps
Oct. 31, 2012
5.625% Senior Notes Due October 2012
Interest rate swaps
Feb. 24, 2013
4.500% Senior Notes Due October 2021
Senior Notes
Feb. 24, 2013
Forward contracts
Darden Stock Units
Oct. 31, 2012
Forward contracts
5.625% Senior Notes Due October 2012
Interest rate swaps
Feb. 24, 2013
Forward contracts
5.625% Senior Notes Due October 2012
Interest rate swaps
Derivative [Line Items]                                  
Contract expiration date           Sep. 01, 2013                      
Notional value of derivative instrument                       $ 250,000,000         $ 300,000,000
Instruments settled cumulative loss recorded in accumulated other comprehensive income (loss) and will be reclassified into earnings as an adjustment to interest expense                               55,000,000  
Face amount of debt                     350,000,000     400,000,000      
Interest rate of debt                     5.625%     4.50%      
Maturity date of debt                     Oct. 01, 2012            
Ineffective portion of interest rate hedge     0                            
Notional value of swaps                         150,000,000        
Reduction to interest expense related to net swap settlements 400,000 700,000 2,500,000 2,200,000                          
Vesting period                 4 years 5 years              
Forward contract indexed to issuer's equity, indexed shares         0.5                   1.2    
Common stock at forward contract rate             $ 47.07 $ 51.95 $ 29.28 $ 52.66              
Amount of loss reclassified from AOCI to earnings (effective portion)     $ (9,500,000)